Title |
Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program |
|---|---|
Involved |
Markus Möhler (Verfasser)
Irina Gepfner-Tuma (Sonstige) Annett Maderer (Sonstige) Peter C. Thuss-Patience (Sonstige)
Joern Ruessel (Sonstige)
Susanna Hegewisch-Becker (Sonstige) Hansjochen Wilke (Sonstige) Salah-Eddin al- Batran (Sonstige) Mohammad-Reza Rafiyan (Sonstige) Florian Weißinger (Sonstige) Hans-Joachim Schmoll (Sonstige) Frank Kullmann (Sonstige) Ludwig Fischer von Weikersthal (Sonstige) Jens Siveke (Sonstige) Jens Weusmann (Sonstige) Stephan Kanzler (Sonstige) Carl Christoph Schimanski (Sonstige) Melanie Otte (Sonstige) Lukas Schollenberger (Sonstige) Jochem Koenig (Sonstige) Peter R. Galle (Sonstige) SpringerLink (Online service) (Sonstige) |
Published in |
BMC cancer 16, 1, 31.8.2016, date:12.2016, Seite 1-13 |
Published |
2016 |
Language |
|
Country |
|
Topic |
|
Subject |
|
DDC notation |
|
Persistent identifier |
urn:nbn:de:1111-201703204546 (URN) |
Record ID |
1128112329 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: